Neurobiology of Depression and Novel Antidepressant Drug Targets

By  

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-12 ,pp. : 5791-5801

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Disorders of Consciousness: Recent Advances in Neurobiology and Treatments)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 26, 2014-08 ,pp. : 4119-4120

Bentham Science Publishers

Access to resources Recommend Favorite

Exposure-Response modeling of anti-depressant treatments: the confounding role of placebo effect

By Goyal Navin  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 3, 2013-06 ,pp. : 389-399

Springer Publishing Company

Access to resources Recommend Favorite

Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder

By  

Current Pharmaceutical Design, Vol. 21, Iss. 34, 2015-10 ,pp. : 4972-4979

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors have antidepressant-like properties in mice - 1. Acute treatments are active in the forced swim test

By Harkin A.J.   Bruce K.H.   Craft B.   Paul I.A.  

European Journal of Pharmacology, Vol. 372, Iss. 3, 1999-05 ,pp. : 207-213

Elsevier

Access to resources Recommend Favorite